Research progress and existing problems in the industrialization of stem cell drugs
10.11665/j.issn.1000-5048.2023111604
- VernacularTitle:干细胞药物产业化研究进展及存在问题
- Author:
Xiao LU
1
;
Xingru WANG
;
Xueyong QI
;
Lianming LIAO
;
Yunfei LIAN
Author Information
1. 江苏拓弘康恒医药有限公司
- Publication Type:Journal Article
- Keywords:
stem cell / industrialization / effectiveness / quality control
- From:
Journal of China Pharmaceutical University
2024;55(2):270-280
- CountryChina
- Language:Chinese
-
Abstract:
Abstract: Stem cells, which are a type of primitive cells with multipotent differentiation potential and self-renewal ability, have the potential to regenerate various tissues and organs. Stem cell drug development is a frontier research field in life sciences. Extensive clinical trials involving stem cells have been conducted for different complicated diseases. Some stem cells have been approved as drugs for some indications, indicating their broad industrial prospects. This review introduces the progress of stem cell drugs around the world, especially in China, and discusses the main problems in the industrialization of stem cell drugs, such as their effectiveness, quality control and safety, so as to provide some reference and insight for the development and rapid industrialization of stem cell drugs.
